This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
2-FMA: Difference between revisions
>Kenan |
>Nicocopedia m Due to 2-FMA being a fluorinated analog (at the 2-position) of methamphetamine, some individuals have reported effects resembling the release serotonin as well. Although this appears to be only present at dosages above the 'Heavy' range (100mg+). Caution |
||
| Line 17: | Line 17: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | {{pharmacology}} | ||
Although 2-FMA has not been formally studied on the same level as traditional [[amphetamines]], it is thought that it acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively increases the levels of the norepinephrine and dopamine in the brain by binding to and partially blocking the transporter proteins that normally remove them from the [[synaptic cleft]]. This allows dopamine and norepinephrine to accumulate within the brain, resulting in stimulating and euphoric effects. | Although 2-FMA has not been formally studied on the same level as traditional [[amphetamines]], it is thought that it acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively increases the levels of the norepinephrine and dopamine in the brain by binding to and partially blocking the transporter proteins that normally remove them from the [[synaptic cleft]]. This allows dopamine and norepinephrine to accumulate within the brain, resulting in stimulating and euphoric effects. | ||
Due to 2-FMA being a fluorinated analog (at the 2-position) of methamphetamine, some individuals have reported effects resembling the release serotonin as well. Although this appears to be only present at dosages above the 'Heavy' range (100mg+). Caution is advised if one chooses to dose heavily and repeatedly, due to its potential towards serotonin releasing activity. | |||
==Subjective effects== | ==Subjective effects== | ||
| Line 146: | Line 148: | ||
==References== | ==References== | ||
<references/> | <references /> | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||